Skip to main content

Nasdaq IPOs

Oral capsule developer Rani Therapeutics files for a $100 million IPO

5 years 3 months ago
Rani Therapeutics, which develops ingestible capsules for oral dosing of medication, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Rani Therapeutics is a clinical stage biotherapeutics company advancing technologies to enable the developm
Renaissance Capital

Pain-free investing: Nalu Medical files for a $100 million IPO

5 years 3 months ago
Nalu Medical, which is commercializing a nerve stimulation implant for chronic neuropathic pain, filed on Friday with the SEC to raise up to $100 million.Nalu states that its miniaturized implantable pulse generator (IPG) delivers gentle electrical pulses to the nervous system to
Renaissance Capital

Oncology biotech Immuneering files for a $100 million IPO

5 years 3 months ago
Immuneering, a preclinical biotech targeting signaling pathways to treat cancer and neurological diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Immuneering's oncology programs target mutations of the MAPK and mTOR pathways, whic
Renaissance Capital

Gene therapy biotech Omega Therapeutics files for a $100 million IPO

5 years 3 months ago
Omega Therapeutics, a preclinical biotech developing gene therapies for cancer and other diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Omega Therapeutics aims to use its proprietary OMEGA Epigenomic Programming platform to pion
Renaissance Capital
Checked
15 minutes 15 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed